XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2019 $ 1,742 $ 40,633,670 $ (28,937,705) $ 11,697,707
Balance (in shares) at Dec. 31, 2019 5,281,237      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 124,992 0 124,992
Issuance of common stock, net of issuance costs $ 3,299 11,966,703 0 11,970,002
Issuance of common stock, net of issuance costs (in shares) 10,000,000      
Issuance of common stock for warrant exercise $ 22 70,437 0 70,459
Issuance of common stock for warrant exercise (in shares) 65,240      
Issuance of common stock from 401K match $ 1 9,799 0 9,800
Issuance of common stock from 401K match (in shares) 3,968      
Net loss $ 0 0 (3,985,408) (3,985,408)
Balance at Mar. 31, 2020 $ 5,064 52,805,601 (32,923,113) 19,887,552
Balance (in shares) at Mar. 31, 2020 15,350,445      
Balance at Dec. 31, 2020 $ 7,346 70,907,315 (43,785,085) 27,129,576
Balance (in shares) at Dec. 31, 2020 22,261,619      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 257,622 0 257,622
Issuance of common stock from 401K match $ 0 35,747 0 35,747
Issuance of common stock from 401K match (in shares) 16,642      
Net loss $ 0 0 (3,048,618) (3,048,618)
Balance at Mar. 31, 2021 $ 7,346 $ 71,200,684 $ (46,833,703) $ 24,374,327
Balance (in shares) at Mar. 31, 2021 22,278,261